Clinical Trial Update: Efficacy Study of Iguratimod Combined With Tofacitab in Patients With RF Positive/Negative Rheumatoid Arthritis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the efficacy of iguratimod combined with tofacitab in rheumatoid arthritis (RF positive/negative).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Iguratimod (iguratimod)
• tofacitab (tofacitab)

Snippet

Sponsor: Yanfeng Hou | Conditions: Rheumatoid Arthritis, Therapy | Phase 4 | Status: UNKNOWN